These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38264367)

  • 1. Acute Extrapyramidal Side Effects Associated With the Combined Use of Low Doses of Haloperidol and Clarithromycin.
    Gunes S; Inal Ulutas G; Sefik P; Ozluk HK; Tanrikulu EE
    Cureus; 2023 Dec; 15(12):e51020. PubMed ID: 38264367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine for tic disorder: a case report.
    Chan-Ob T; Kuntawongse N; Boonyanaruthee V
    J Med Assoc Thai; 2001 Nov; 84(11):1624-8. PubMed ID: 11853307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
    Tauscher J; Küfferle B; Asenbaum S; Tauscher-Wisniewski S; Kasper S
    Psychopharmacology (Berl); 2002 Jun; 162(1):42-9. PubMed ID: 12107616
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Grubor M; Zivkovic M; Sagud M; Nikolac Perkovic M; Mihaljevic-Peles A; Pivac N; Muck-Seler D; Svob Strac D
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis.
    Siafis S; Wu H; Wang D; Burschinski A; Nomura N; Takeuchi H; Schneider-Thoma J; Davis JM; Leucht S
    Mol Psychiatry; 2023 Aug; 28(8):3267-3277. PubMed ID: 37537284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons.
    Haddad PM; Das A; Keyhani S; Chaudhry IB
    J Psychopharmacol; 2012 May; 26(5 Suppl):15-26. PubMed ID: 22057019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV; Dellva MA; Tollefson GD; Beasley CM; Potvin JH; Kiesler GM
    J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertindole for schizophrenia.
    Lewis R; Bagnall AM; Leitner M
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD001715. PubMed ID: 16034864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Extrapyramidal Side Effects from Smoked Haloperidol.
    Pham A; Lee JY; Miller CWT
    Case Rep Psychiatry; 2021; 2021():4177263. PubMed ID: 34635875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.
    Gao K; Kemp DE; Ganocy SJ; Gajwani P; Xia G; Calabrese JR
    J Clin Psychopharmacol; 2008 Apr; 28(2):203-9. PubMed ID: 18344731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.
    Grauer SM; Graf R; Navarra R; Sung A; Logue SF; Stack G; Huselton C; Liu Z; Comery TA; Marquis KL; Rosenzweig-Lipson S
    Psychopharmacology (Berl); 2009 May; 204(1):37-48. PubMed ID: 19107466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders.
    Tatara A; Shimizu S; Shin N; Sato M; Sugiuchi T; Imaki J; Ohno Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):252-9. PubMed ID: 22542492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleanolic acid alleviates the extrapyramidal symptoms and cognitive impairment induced by haloperidol through the striatal PKA signaling pathway in mice.
    Kong CH; Cho K; Min JW; Kim JY; Park K; Kim DY; Jeon M; Kang WC; Jung SY; Lee JY; Ryu JH
    Biomed Pharmacother; 2023 Dec; 168():115639. PubMed ID: 37812895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia.
    Weng J; Zhang Y; Li H; Shen Y; Yu W
    Gen Psychiatr; 2019; 32(1):e100026. PubMed ID: 31179423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
    Arora D; Mudgal J; Nampoothiri M; Mallik SB; Kinra M; Hall S; Anoopkumar-Dukie S; Grant GD; Rao CM
    Metab Brain Dis; 2018 Aug; 33(4):1045-1051. PubMed ID: 29516413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapyramidal Side Effects in a Patient with Alcohol Withdrawal Symptoms: A Reflection of Quality of the Mental Health Care System.
    Kaggwa MM; Nkola R; Najjuka SM; Bongomin F; Ashaba S; Mamun MA
    Risk Manag Healthc Policy; 2021; 14():2789-2795. PubMed ID: 34234593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.
    Matsui-Sakata A; Ohtani H; Sawada Y
    Drug Metab Pharmacokinet; 2005 Jun; 20(3):187-99. PubMed ID: 15988121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: iodine-123-iodobenzamide single photon emission computed tomography study.
    Corripio I; Ferreira A; Portella MJ; Pérez V; Escartí MJ; Del Valle Camacho M; Sauras RB; Alonso A; Grasa EM; Carrió I; Catafau AM; Alvarez E
    Psychiatry Res; 2012 Jan; 201(1):73-7. PubMed ID: 22281201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.